» Articles » PMID: 22426080

Ocular Surface Immunity: Homeostatic Mechanisms and Their Disruption in Dry Eye Disease

Overview
Specialty Ophthalmology
Date 2012 Mar 20
PMID 22426080
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

The tear film, lacrimal glands, corneal and conjunctival epithelia and Meibomian glands work together as a lacrimal functional unit (LFU) to preserve the integrity and function of the ocular surface. The integrity of this unit is necessary for the health and normal function of the eye and visual system. Nervous connections and systemic hormones are well known factors that maintain the homeostasis of the ocular surface. They control the response to internal and external stimuli. Our and others' studies show that immunological mechanisms also play a pivotal role in regulating the ocular surface environment. Our studies demonstrate how anti-inflammatory factors such as the expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in corneal cells, immature corneal resident antigen-presenting cells, and regulatory T cells play an active role in protecting the ocular surface. Dry eye disease (DED) affects millions of people worldwide and negatively influences the quality of life for patients. In its most severe forms, DED may lead to blindness. The etiology and pathogenesis of DED remain largely unclear. Nonetheless, in this review we summarize the role of the disruption of afferent and efferent immunoregulatory mechanisms that are responsible for the chronicity of the disease, its symptoms, and its clinical signs. We illustrate current anti-inflammatory treatments for DED and propose that prevention of the disruption of immunoregulatory mechanisms may represent a promising therapeutic strategy towards controlling ocular surface inflammation.

Citing Articles

Research progress on the immune mechanism of thyroid-related eye disease combined with dry eye.

Wang Y, Chen D, Jin L, Li D J Ophthalmic Inflamm Infect. 2025; 15(1):23.

PMID: 40063329 PMC: 11893917. DOI: 10.1186/s12348-025-00477-7.


Global research hotspots and trends in anti-inflammatory studies in dry eye: a bibliometric analysis (2004-2024).

Wang S, Zheng W, Li T, Yu D, Zhang Q, Ju Y Front Med (Lausanne). 2024; 11:1451990.

PMID: 39669988 PMC: 11634594. DOI: 10.3389/fmed.2024.1451990.


Morphological aberration of corneal nerves in hyposecretory dry eye guinea pigs.

Kiyoi T, He Q, Liu L, Zheng S, Nakazawa H, Uwada J Med Mol Morphol. 2024; 58(1):34-42.

PMID: 39542915 DOI: 10.1007/s00795-024-00407-x.


Immunopathology of Corneal Allograft Rejection and Donor-Specific Antibodies (DSAs) as Immunological Predictors of Corneal Transplant Failure.

Olejkowska N, Gorczyca I, Rekas M, Garley M Cells. 2024; 13(18.

PMID: 39329716 PMC: 11430735. DOI: 10.3390/cells13181532.


Meibomian gland dropout of upper eyelids as a novel biomarker for early diagnosis of primary Sjögren's syndrome: a pilot study.

Wu J, Liang Y, Shi F, Tu X, Zhang J, Qiu Q Ther Adv Musculoskelet Dis. 2024; 16:1759720X241274726.

PMID: 39228398 PMC: 11369872. DOI: 10.1177/1759720X241274726.


References
1.
Yeh S, Song X, Farley W, Li D, Stern M, Pflugfelder S . Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci. 2002; 44(1):124-9. DOI: 10.1167/iovs.02-0581. View

2.
Sullivan D, Jensen R, Suzuki T, Richards S . Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands?. Mol Vis. 2009; 15:1553-72. PMC: 2728565. View

3.
Sainz De La Maza Serra M , Simon Castellvi C , Kabbani O . [Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca]. Arch Soc Esp Oftalmol. 2001; 75(11):751-756. View

4.
Jie Y, Xu L, Wu Y, Jonas J . Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond). 2008; 23(3):688-93. DOI: 10.1038/sj.eye.6703101. View

5.
Huehn J, Hamann A . Homing to suppress: address codes for Treg migration. Trends Immunol. 2005; 26(12):632-6. DOI: 10.1016/j.it.2005.10.001. View